Explore MDMB-FUBICA | PiHKAL · info

Exploring MDMB-FUBICA. To explore a different substance…

Name

MDMB-FUBICA

IUPAC names

Methyl N-{1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}-3-methyl-L-valinate
Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}amino)-3,3-dimethylbutanoate

ID 4517 · Formula C₂₃H₂₅FN₂O₃ · Molecular weight 396.455

Tags Cannabinoid

InChI InChI=1S/C23H25FN2O3/c1-23(2,3)20(22(28)29-4)25-21(27)18-14-26(19-8-6-5-7-17(18)19)13-15-9-11-16(24)12-10-15/h5-12,14,20H,13H2,1-4H3,(H,25,27)/t20-/m1/s1

InChI Key RVAWIZIGOSKPBP-HXUWFJFHSA-N This stereoisomer Any stereoisomer

SMILES COC(=O)[C@H](C(C)(C)C)NC(=O)c1cn(c2c1cccc2)Cc1ccc(cc1)F

ChemSpider 57621561
PubChem 129522107
Project Response MDMB-FUBICA (1766-17)

Doi, T; Tagami, T; Takeda, A; Asada, A; Sawabe, Y. Evaluation of carboxamide-type synthetic cannabinoids as CB₁/CB₂ receptor agonists: difference between the enantiomers Forensic Toxicol., 1 Jan 2018, 36 (1), 51-60. 698 kB. https://doi.org/10.1007/s11419-017-0378-5 #17 NMR

EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #35

Abbate, V; Schwenk, M; Presley, BC; Uchiyama, N. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report) Pure Appl. Chem., 28 Aug 2018, 90 (8), 1255–1282. 1.0 MB. https://doi.org/10.1515/pac-2017-0605 #7. MDMB-FUBICA

Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #75

Patel, M; Manning, JJ; Finlay, DB; Javitch, JA; Banister, SD; Grimsey, NL; Glass, M. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists Biochem. Pharmacol., 1 May 2020, 175 113871. 1.9 MB. https://doi.org/10.1016/j.bcp.2020.113871 #MDMB-FUBICA

Wouters, E; Mogler, L; Cannaert, A; Auwärter, V; Stove, C. Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐ tert ‐leucine Drug Test. Anal., 1 Aug 2019, 11 (8), 1183–1191. 1.4 MB. https://doi.org/10.1002/dta.2607 #18

Wagmann, L; Stiller, RG; Fischmann, S; Westphal, F; Meyer, MR. Going deeper into the toxicokinetics of synthetic cannabinoids: In vitro contribution of human carboxylesterases Arch. Toxicol., 1 Nov 2022, 96 (10), 2755–2766. 1.6 MB. https://doi.org/10.1007/s00204-022-03332-z #MDMB-FUBICA

MPP-4F-BUTICA

7 Dec 2019 · · Isomer Design